Division of Research Spotlight
The Kaiser Permanente Division of Research conducts, publishes, and disseminates epidemiologic and health services research to improve the health and medical care of Kaiser Permanente members and society at large. We seek to understand the determinants of illness and well-being, and to improve the quality and cost-effectiveness of health care. Currently, DOR’s 550-plus staff is working on more than 350 epidemiological and health services research projects.
In a long-term national study, breastfeeding for six months or longer cuts the risk of developing type 2 diabetes nearly in half for women throughout their childbearing years, according to new Kaiser Permanente research published Jan. 16 in JAMA Internal Medicine.
A new study from the Division of Research, using data from almost 300,000 pregnant women treated at Kaiser Permanente Northern California, found that maternal prenatal marijuana use increased from 4 to 7 percent from 2009 to 2016.
Kaiser Permanente hospitals in Northern California are delivering clot-busting medication to new stroke patients more than twice as fast as the national average. This follows the region-wide adoption of an integrated telemedicine program, according to new research published December 15 in the journal Stroke.
Analysis of DNA from nearly 70,000 Kaiser Permanente Northern California patients uncovered 47 specific positions, or loci, in the genome that are associated with variations in pressure inside the eye. The findings could help clarify how elevated eye pressure leads to glaucoma.
A Kaiser Permanente study of real-world exposure to non-ionizing radiation from magnetic fields in pregnant women found a significantly higher rate of miscarriage, providing new evidence regarding their potential health risks.
Compared with the non-Hispanic white (NHW) population, the urban American-Indian and Alaskan Native (AIAN) community was more likely to have lower survival rates following invasive prostate and breast cancer, according to results published by Kaiser Permanente researchers and colleagues in Cancer Research, a journal of the American Association for Cancer Research.
Alan Go, MD, of the Kaiser Permanente Division of Research, and Kaiser Permanente Northern California oncologist Louis Fehrenbacher, MD, are among the less than 400 people named as Highly Cited Researchers in clinical medicine for 2017 by Clarivate Analytics. The annual list recognizes investigators whose research ranks in the top 1 percent most cited works in their field, indicating exceptional scientific impact.
A new study – designed with the direct assistance of Kaiser Permanente members who use kp.org – shows just how valuable the patient portal has become for helping family members to participate in each other’s care.
The Division of Research’s Stephen Sidney, MD, MPH was honored by the National Forum for Heart Disease and Stroke Prevention for his “exceptional contributions” as well as his work on understanding national trends in cardiovascular disease.
Patients with cancer often face barriers to optimal care, and Devon Check, PhD, a second-year Delivery Science Fellow in the Kaiser Permanente Division of Research, seeks to understand these hurdles inside and out.